UC | CD | |
---|---|---|
N | 15 | 25 |
Gender (n) | ||
Female | 4 | 11 |
Male | 11 | 14 |
Age median (range) | 25 (16-57) | 33 (18-51) |
Disease duration (y) (median, range) | 1-40 (10,7) | 1-25 (9,6) |
Smokers | 0 | 0 |
Disease severity (UCDAI, HB) (n) | ||
Mild | 1 | |
Moderate | 13 | |
Severe | ||
>5 in HB (range) | 24 (5-27) | |
Previous medication (n) | ||
Aminosalicylates | 15 | 25 |
Glucocorticosteroids | 15 | 25 |
Immunomodulators (6-MP/AZA) | 15 | 25 |
Infliximab | 9 | |
Antibiotics | 12 | 23 |
Patients with extraintestinal manifestations (n) | 4 | 12 |
Patients with previous abdominal surgery for IBD (n) | 4 | 6 |
Patients with perianal fistulas (n) | 5 | |
Disease location | ||
Extensive | 6 | |
Left side | 7 | |
Proctitis | 2 | |
Extensive colonic | 21 | |
Small bowel + colonic | 1 | |
Esofagus + small bowel | 1 | |
Stomach + small bowel + colonic | 1 |